Effect of platelet-activating factor receptor antagonist, etizolam, on resolution of chronic subdural hematoma - A prospective study to investigate use as conservative therapy

Neurologia Medico-Chirurgica

Volumn 45, Issue 12, 2005, Pages 621-626

  Hirashima, Yutaka ^a   Kurimoto, Masanori ^a   Nagai, Shoichi ^a   Hori, Emiko ^a   Origasa, Hideki ^a   Endo, Shunro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Chronic subdural hematoma; Computed tomography; Etizolam; Platelet activating factor receptor antagonist

Indexed keywords

ETIZOLAM; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DENSITY; DRUG EFFECT; FEMALE; GENDER; HUMAN; HYGROMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROSURGERY; PARESIS; PREDICTION; PREDICTOR VARIABLE; SOMNOLENCE; SUBDURAL HEMATOMA; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADMINISTRATION, ORAL; AGED; DIAZEPAM; FEMALE; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; MALE; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEINS; PROSPECTIVE STUDIES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 29544437656     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.45.621     Document Type: Article

References (25)

1. Bender MB, Christoff N: Nonsurgical treatment of subdural hematomas. Arch Neurol 31: 73-79, 1974
2. Bergstrom M, Ericson K, Levander B, Svendsen P, Larsson S: Computed tomography of cranial subdural and epidural hematomas: variation of attenuation related to time and clinical events such as rebleeding. J Comput Assist Tomogr 1: 445-449, 1977
3. Camussi G, Aglietta M, Coda R, Bussolino F, Piacibello W, Tetta C: Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology 42: 191-199, 1981
4. Chap H, Mauco G, Simon MF, Benveniste J, Douste-Nlazy L: Biosynthetic labeling of platelet activating factor from radioactive acetate by stimulated platelets. Nature 289: 312-314, 1981
5. Gjerris F, Schmidt K: Chronic subdural hematoma: surgery or mannitol treatment. J Neurosurg 40: 639-642, 1974
6. Glover D, Labadie EL: Physiopathogenesis of subdural hematomas. Part 2: Inhibition of growth of experimental hematomas with dexamethasone. J Neurosurg 45: 393-397, 1976
7. Hirashima Y, Endo S, Hayashi N, Karasawa K, Nojima S, Takaku A: Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers. Acta Neurochir (Wien) 137: 15-18, 1995
8. Hirashima Y, Endo S, Kato R, Ohmori T, Nagahori T, Nishijima M, Karasawa K, Nojima S, Takaku A: Platelet-activating factor (PAF) and the development of chronic subdural haematoma. Acta Neurochir (Wien) 129: 20-25, 1994
9. Hirashima Y, Kuwayama N, Hamada H, Hayashi N, Endo S: Etizolam, an anti-anxiety agent, attenuates recurrence of chronic subdural hematoma. Evaluation by computed tomography. Neurol Med Chir (Tokyo) 42: 53-56, 2002
10. Labadle EL, Glover D: Physiopathogenesis of subdural hematomas. Part 1: Histological and biochemical comparisons of subcutaneous hematoma in rats with subdural hematoma in man. J Neurosurg 45: 382-392, 1976
11. Lee KS: Natural history of chronic subdural haematoma. Brain Inj 18: 351-358, 2004
12. Lee TG, Lenihan DJ, Malone B, Roddy LL, Wasserman SJ: Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem 259: 5526-5530, 1984
13. Murakami M, Morikawa K, Matsuno A, Kaneda K, Nagashima T: Spontaneous intracranial hypotension associated with bilateral chronic subdural hematomas - case report. Neurol Med Chir (Tokyo) 40: 484-488, 2000
14. Naganuma H, Fukamachi A, Kawakami M, Misumi S, Nakajima H, Wakao T: Spontaneous resolution of chronic subdural hematomas. Neurosurgery 19: 794-798, 1986
15. Nakamura N, Ogawa T, Hashimoto T, Yuki K, Kobayashi S: [Reevaluation on resolving subdural hematoma]. Neurol Med Chir (Tokyo) 21: 491-500, 1981 (Jpn, with Eng abstract)
16. Parlato C, Guarracino A, Moraci A: Spontaneous resolution of chronic subdural hematoma. Surg Neurol 53: 312-315, 2000
17. Prescott SM, Zimmerman GA, McIntyre TM: Human endothelial cells in culture produce platelet-activating factor (1-alkyl-Z-acetyl-sn-glycero-3- phosphocholin) when stimulated with thrombin. Proc Natl Acad Sci U S A 81: 3534-3538, 1984
18. Sakaki S, Bito S, Hayashi M, Yoshikawa K: [Clinicopathological studies on the cases of chronic subdural hematomas - about pathogenesis of hematoma and mechanism of manifestation of symptoms]. No To Shinkei 25: 153-162, 1973 (Jpn)
19. Schievink WI, Morreale VM, Atkinson JL, Meyer FB, Piepgras DG, Ebersold MJ: Surgical treatment of spontaneous spinal cerebrospinal fluid leaks. J Neurosurg 88: 243-246, 1998
20. Suzuki J, Takaku A: Nonsurgical treatment of chronic subdural hematomas. J Neurosurg 33: 548-553, 1970
21. Tamura N, Agrawal DK, Suliaman FA, Townley RG: Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun 142: 638-644, 1987
22. Ulmer S, Engellandt K, Stiller U, Nabavi A, Jansen O, Mehdorn MH: Chronic subdural hemorrhage into a giant arachnoid cyst (Galaai classification type III). J Comput Assist Tomogr 26: 647-653, 2002
23. Wardlaw AJ, Mogbel R, Cromwell O, Kay AB: Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78: 1701-1706, 1986
24. Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S: Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 98: 1217-1221, 2003
25. Yamashima T, Kubota T, Yamamoto S: Eosinophil degranulation in the capsule of chronic subdural hematomas. J Neurosurg 62: 257-260, 1985